DGX inventory slips as outlook disappoints amid hit to COVID-19 check income (NYSE:DGX)


Rolled newspaper with the headline Quarterly Results

Zerbor/iStock by way of Getty Photographs

Regardless of reporting higher than anticipated This autumn 2022 financials, Quest Diagnostics (NYSE:DGX) shed ~2% within the morning hours Thursday as the corporate set its 2023 income outlook under consensus amid falling income linked to COVID-19 testing.

“COVID-19 testing revenues

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles